Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 05/2019
Journal Article
JAMA Pediatrics, ISSN 2168-6203, 12/2016, Volume 170, Issue 12, pp. 1142 - 1144
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 11/2016, Volume 214, Issue 9, pp. 1297 - 1299
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S338 - S338
Abstract Background The electronic medical record (EMR) has become a modern compendium of health information, from broad clinical assessments down to an...
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S802 - S803
Abstract Background There is limited data on the indirect and non-medical costs associated with congenital cytomegalovirus (cCMV). Attempts to predict the...
Journal Article
6.
Full Text
1750. Epidemiology of Cytomegalovirus DNAemia in Pediatric Solid-Organ Transplant Patients
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S641 - S642
Abstract Background Despite the widespread use of prevention strategies, CMV remains a common opportunistic infection in SOTR. Contemporary data regarding CMV...
Journal Article
Science, ISSN 0036-8075, 7/2009, Volume 325, Issue 5937, pp. 197 - 201
Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages...
H1N1 subtype influenza A virus | Maps | Pandemics | Influenza A virus | Swine | Environmental laboratories | Viruses | Orthomyxoviridae | Reports | Genomes | Public health | A VIRUS | UNITED-STATES | PIGS | TRANSMISSION | EVOLUTION | PATHOGENICITY | PHYLOGENETIC ANALYSIS | MULTIDISCIPLINARY SCIENCES | INFECTION | EMERGENCE | NORTH-AMERICA | Influenza A Virus, H1N1 Subtype - immunology | Viral Matrix Proteins - genetics | Influenza A Virus, H1N1 Subtype - classification | Swine Diseases - virology | Humans | Influenza A virus - genetics | Neuraminidase - genetics | Reassortant Viruses - genetics | Antigens, Viral - genetics | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H3N2 Subtype - genetics | Phylogeny | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Genetic Variation | Hemagglutination Inhibition Tests | Influenza A Virus, H1N1 Subtype - isolation & purification | Disease Outbreaks | Genes, Viral | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Genome, Viral | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Orthomyxoviridae Infections - veterinary | Viral Nonstructural Proteins - genetics | Influenza, Human - epidemiology | Antigens, Viral - immunology | Animals | Antibodies, Viral - immunology | Mutation | Orthomyxoviridae Infections - virology | Evolution, Molecular | Influenza, Human - immunology | Influenza viruses | Genetic aspects | Research | Health aspects | Swine influenza
H1N1 subtype influenza A virus | Maps | Pandemics | Influenza A virus | Swine | Environmental laboratories | Viruses | Orthomyxoviridae | Reports | Genomes | Public health | A VIRUS | UNITED-STATES | PIGS | TRANSMISSION | EVOLUTION | PATHOGENICITY | PHYLOGENETIC ANALYSIS | MULTIDISCIPLINARY SCIENCES | INFECTION | EMERGENCE | NORTH-AMERICA | Influenza A Virus, H1N1 Subtype - immunology | Viral Matrix Proteins - genetics | Influenza A Virus, H1N1 Subtype - classification | Swine Diseases - virology | Humans | Influenza A virus - genetics | Neuraminidase - genetics | Reassortant Viruses - genetics | Antigens, Viral - genetics | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H3N2 Subtype - genetics | Phylogeny | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Genetic Variation | Hemagglutination Inhibition Tests | Influenza A Virus, H1N1 Subtype - isolation & purification | Disease Outbreaks | Genes, Viral | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Genome, Viral | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Orthomyxoviridae Infections - veterinary | Viral Nonstructural Proteins - genetics | Influenza, Human - epidemiology | Antigens, Viral - immunology | Animals | Antibodies, Viral - immunology | Mutation | Orthomyxoviridae Infections - virology | Evolution, Molecular | Influenza, Human - immunology | Influenza viruses | Genetic aspects | Research | Health aspects | Swine influenza
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 05/2008, Volume 27, Issue 5, pp. 425 - 430
BACKGROUND:Neonatal herpes simplex virus (HSV) infection can cause significant morbidity and mortality but can be difficult to identify, particularly in...
neonatal | laboratory features | case-control | clinical features | herpes viruses | INFECTIOUS DISEASES | NEWBORN | MOTHER | IMMUNOLOGY | NATURAL-HISTORY | ACYCLOVIR | ENCEPHALITIS | INFANTS | PEDIATRICS | Herpes Simplex - physiopathology | Herpes Simplex - diagnosis | Thrombocytopenia - etiology | Humans | Mothers | Case-Control Studies | Respiratory Distress Syndrome, Newborn - etiology | Fever of Unknown Origin - etiology | Herpes Simplex - pathology | Simplexvirus - isolation & purification | Texas | Female | Retrospective Studies | Infant, Newborn | Maternal Welfare
neonatal | laboratory features | case-control | clinical features | herpes viruses | INFECTIOUS DISEASES | NEWBORN | MOTHER | IMMUNOLOGY | NATURAL-HISTORY | ACYCLOVIR | ENCEPHALITIS | INFANTS | PEDIATRICS | Herpes Simplex - physiopathology | Herpes Simplex - diagnosis | Thrombocytopenia - etiology | Humans | Mothers | Case-Control Studies | Respiratory Distress Syndrome, Newborn - etiology | Fever of Unknown Origin - etiology | Herpes Simplex - pathology | Simplexvirus - isolation & purification | Texas | Female | Retrospective Studies | Infant, Newborn | Maternal Welfare
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2009, Volume 46, Issue 4, pp. S1 - S5
Abstract Key awareness issues surrounding congenital CMV infection are outlined and discussed to provide inspirational motivation for many diverse groups who...
Infectious Disease | Allergy and Immunology | Action | Congenital | Awareness | Cytomegalovirus (CMV) | Public health | UNITED-STATES | MOTHERS | VIRUS | SEROPREVALENCE | CHILDREN | HEARING-LOSS | WOMEN | VIROLOGY | DISEASE | INFECTION | EPIDEMIOLOGY | Health Services | Humans | Prenatal Diagnosis | Cytomegalovirus Infections - diagnosis | Health Knowledge, Attitudes, Practice | Neonatal Screening | Antibodies, Viral - blood | Pregnancy | Cytomegalovirus Infections - prevention & control | Cytomegalovirus Infections - drug therapy | Pregnancy Complications, Infectious - drug therapy | Pregnancy Complications, Infectious - prevention & control | Female | Cytomegalovirus Infections - congenital | Cytomegalovirus Vaccines - immunology | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Pregnancy Complications, Infectious - diagnosis | Prevention | Virus diseases | Care and treatment | Genetic disorders | Pregnant women
Infectious Disease | Allergy and Immunology | Action | Congenital | Awareness | Cytomegalovirus (CMV) | Public health | UNITED-STATES | MOTHERS | VIRUS | SEROPREVALENCE | CHILDREN | HEARING-LOSS | WOMEN | VIROLOGY | DISEASE | INFECTION | EPIDEMIOLOGY | Health Services | Humans | Prenatal Diagnosis | Cytomegalovirus Infections - diagnosis | Health Knowledge, Attitudes, Practice | Neonatal Screening | Antibodies, Viral - blood | Pregnancy | Cytomegalovirus Infections - prevention & control | Cytomegalovirus Infections - drug therapy | Pregnancy Complications, Infectious - drug therapy | Pregnancy Complications, Infectious - prevention & control | Female | Cytomegalovirus Infections - congenital | Cytomegalovirus Vaccines - immunology | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Pregnancy Complications, Infectious - diagnosis | Prevention | Virus diseases | Care and treatment | Genetic disorders | Pregnant women
Journal Article
10.
Full Text
Editorial commentary: cytomegalovirus infection: back to the future or no more elephants?
Clinical Infectious Diseases, ISSN 1058-4838, 11/2006, Volume 43, Issue 9, p. 1152
Journal Article
Pediatrics, ISSN 0031-4005, 03/2017, Volume 139, Issue 3, p. e20162610
OBJECTIVES: To assess the prevalence, characteristics, and risk of sensorineural hearing loss (SNHL) in children with congenital cytomegalovirus infection...
LONG-TERM | SWEDEN | VIRUS INFECTION | INFANTS | DISEASE | PEDIATRICS | NOISE | CMV INFECTION | PREVALENCE | NEWBORNS | THRESHOLDS | Deafness - virology | Prevalence | Asymptomatic Infections - epidemiology | Cytomegalovirus Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Hearing Loss, Sensorineural - epidemiology | Neonatal Screening | Case-Control Studies | Hearing Loss, Sensorineural - diagnosis | Evoked Potentials, Auditory, Brain Stem | Female | Cytomegalovirus Infections - congenital | Child | Infant, Newborn | Texas - epidemiology | Severity of Illness Index | Hearing Loss, Sensorineural - virology | Deafness - epidemiology | Proportional Hazards Models | Cytomegalovirus Infections - diagnosis | Disease Progression | Adolescent | Age of Onset | Physiological aspects | Cytomegalovirus infections | Research | Children | Hearing loss | 32.00
LONG-TERM | SWEDEN | VIRUS INFECTION | INFANTS | DISEASE | PEDIATRICS | NOISE | CMV INFECTION | PREVALENCE | NEWBORNS | THRESHOLDS | Deafness - virology | Prevalence | Asymptomatic Infections - epidemiology | Cytomegalovirus Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Hearing Loss, Sensorineural - epidemiology | Neonatal Screening | Case-Control Studies | Hearing Loss, Sensorineural - diagnosis | Evoked Potentials, Auditory, Brain Stem | Female | Cytomegalovirus Infections - congenital | Child | Infant, Newborn | Texas - epidemiology | Severity of Illness Index | Hearing Loss, Sensorineural - virology | Deafness - epidemiology | Proportional Hazards Models | Cytomegalovirus Infections - diagnosis | Disease Progression | Adolescent | Age of Onset | Physiological aspects | Cytomegalovirus infections | Research | Children | Hearing loss | 32.00
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2009, Volume 46, Issue 4, pp. S22 - S26
Abstract Background Ganciclovir protects against hearing deterioration in infants with symptomatic congenital cytomegalovirus (CMV) disease involving the...
Infectious Disease | Allergy and Immunology | Cytomegalovirus | Developmental outcomes | Ganciclovir | Congenital CMV | Antiviral treatment | Neurologic outcomes | DEVELOPMENTAL SCREENING-TEST | SENSORINEURAL HEARING-LOSS | VACCINE | DENVER | CHILDREN | VIROLOGY | CLINICAL MANIFESTATIONS | INCLUSION DISEASE | Multivariate Analysis | Injections, Intravenous | Antiviral Agents - therapeutic use | Humans | Developmental Disabilities - prevention & control | Infant | Male | Treatment Outcome | Cytomegalovirus Infections - complications | Antiviral Agents - administration & dosage | Regression Analysis | Cytomegalovirus Infections - drug therapy | Ganciclovir - therapeutic use | Female | Central Nervous System - physiopathology | Cytomegalovirus Infections - congenital | Central Nervous System - virology | Developmental Disabilities - virology | Ganciclovir - administration & dosage | Infant, Newborn | Virus diseases | Allergy | Medical colleges | Alanine | Genetic disorders | Clouds | Central nervous system | Infants | Health aspects | Allergic reaction | Index Medicus | antiviral treatment | neurologic outcomes | developmental outcomes | congenital CMV | cytomegalovirus
Infectious Disease | Allergy and Immunology | Cytomegalovirus | Developmental outcomes | Ganciclovir | Congenital CMV | Antiviral treatment | Neurologic outcomes | DEVELOPMENTAL SCREENING-TEST | SENSORINEURAL HEARING-LOSS | VACCINE | DENVER | CHILDREN | VIROLOGY | CLINICAL MANIFESTATIONS | INCLUSION DISEASE | Multivariate Analysis | Injections, Intravenous | Antiviral Agents - therapeutic use | Humans | Developmental Disabilities - prevention & control | Infant | Male | Treatment Outcome | Cytomegalovirus Infections - complications | Antiviral Agents - administration & dosage | Regression Analysis | Cytomegalovirus Infections - drug therapy | Ganciclovir - therapeutic use | Female | Central Nervous System - physiopathology | Cytomegalovirus Infections - congenital | Central Nervous System - virology | Developmental Disabilities - virology | Ganciclovir - administration & dosage | Infant, Newborn | Virus diseases | Allergy | Medical colleges | Alanine | Genetic disorders | Clouds | Central nervous system | Infants | Health aspects | Allergic reaction | Index Medicus | antiviral treatment | neurologic outcomes | developmental outcomes | congenital CMV | cytomegalovirus
Journal Article
The Journal of Pediatrics, ISSN 0022-3476, 07/2003, Volume 143, Issue 1, pp. 16 - 25
Objective: To evaluate the efficacy and safety of ganciclovir therapy in neonates with congenital cytomegalovirus (CMV) disease. Study design: Neonates with...
INCLUSION DISEASE | PHARMACOKINETICS | PARENTS | MOLECULAR EPIDEMIOLOGY | PEDIATRICS | VIRAL TRANSMISSION | INFECTION | DAY-CARE-CENTER | NEWBORNS | CENTERS | CHILDREN | Splenomegaly - chemically induced | Follow-Up Studies | Ganciclovir - adverse effects | Cytomegalovirus Infections - epidemiology | Humans | Infant | Male | Hearing Loss, Sensorineural - epidemiology | Creatinine - metabolism | Hearing Loss, Sensorineural - chemically induced | Hearing Loss, Sensorineural - diagnosis | Time Factors | Hyperbilirubinemia - chemically induced | Ganciclovir - therapeutic use | Female | Cytomegalovirus Infections - congenital | Infant, Newborn | Hyperbilirubinemia - epidemiology | Severity of Illness Index | Double-Blind Method | Antiviral Agents - therapeutic use | Central Nervous System Viral Diseases - congenital | Central Nervous System Viral Diseases - drug therapy | Calcinosis - epidemiology | Hepatomegaly - epidemiology | Cytomegalovirus Infections - drug therapy | Splenomegaly - epidemiology | Antiviral Agents - adverse effects | Hepatomegaly - chemically induced | Infant, Premature | Brain - pathology | Calcinosis - pathology | Evoked Potentials, Auditory, Brain Stem - physiology | Central Nervous System Viral Diseases - epidemiology
INCLUSION DISEASE | PHARMACOKINETICS | PARENTS | MOLECULAR EPIDEMIOLOGY | PEDIATRICS | VIRAL TRANSMISSION | INFECTION | DAY-CARE-CENTER | NEWBORNS | CENTERS | CHILDREN | Splenomegaly - chemically induced | Follow-Up Studies | Ganciclovir - adverse effects | Cytomegalovirus Infections - epidemiology | Humans | Infant | Male | Hearing Loss, Sensorineural - epidemiology | Creatinine - metabolism | Hearing Loss, Sensorineural - chemically induced | Hearing Loss, Sensorineural - diagnosis | Time Factors | Hyperbilirubinemia - chemically induced | Ganciclovir - therapeutic use | Female | Cytomegalovirus Infections - congenital | Infant, Newborn | Hyperbilirubinemia - epidemiology | Severity of Illness Index | Double-Blind Method | Antiviral Agents - therapeutic use | Central Nervous System Viral Diseases - congenital | Central Nervous System Viral Diseases - drug therapy | Calcinosis - epidemiology | Hepatomegaly - epidemiology | Cytomegalovirus Infections - drug therapy | Splenomegaly - epidemiology | Antiviral Agents - adverse effects | Hepatomegaly - chemically induced | Infant, Premature | Brain - pathology | Calcinosis - pathology | Evoked Potentials, Auditory, Brain Stem - physiology | Central Nervous System Viral Diseases - epidemiology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1834 - 1841
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
NEURAMINIDASE INHIBITORS | A(H1N1) VIRUSES | ZANAMIVIR | SUSCEPTIBILITY | SURVEILLANCE | FERRETS | ASSAYS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | ISOLATED WORLDWIDE | SELECTION | Genetic Testing | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Cells, Cultured | Child, Preschool | Molecular Sequence Data | Neuraminidase - genetics | Male | Influenza A Virus, H3N2 Subtype - genetics | Sequence Analysis, DNA | Point Mutation | Drug Resistance, Viral - genetics | Influenza, Human - diagnosis | Influenza, Human - virology | Immunocompromised Host | Influenza, Human - drug therapy | Antiviral Agents
NEURAMINIDASE INHIBITORS | A(H1N1) VIRUSES | ZANAMIVIR | SUSCEPTIBILITY | SURVEILLANCE | FERRETS | ASSAYS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | ISOLATED WORLDWIDE | SELECTION | Genetic Testing | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Cells, Cultured | Child, Preschool | Molecular Sequence Data | Neuraminidase - genetics | Male | Influenza A Virus, H3N2 Subtype - genetics | Sequence Analysis, DNA | Point Mutation | Drug Resistance, Viral - genetics | Influenza, Human - diagnosis | Influenza, Human - virology | Immunocompromised Host | Influenza, Human - drug therapy | Antiviral Agents
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 2, pp. AB171 - AB171
 Mechanisms underlying the latter are less well understood. Since polyclonal human IgG is used in the treatment of certain HCMV infections, we hypothesized...
Allergy and Immunology | Immunoglobulins | Killer cells | Fibroblasts | Cytomegalovirus | Cytotoxicity | Efficiency
Allergy and Immunology | Immunoglobulins | Killer cells | Fibroblasts | Cytomegalovirus | Cytotoxicity | Efficiency
Journal Article
16.
Full Text
Long-term Visual and Ocular Sequelae in Patients With Congenital Cytomegalovirus Infection
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 09/2017, Volume 36, Issue 9, pp. 877 - 882
BACKGROUND:Cytomegalovirus (CMV) is the most common congenital viral infection in the United States. Visual and ocular sequelae in adolescents and adults who...
sequelae | visual | cytomegalovirus | congenital cytomegalovirus | long-term | MORTALITY | INFECTIOUS DISEASES | IMMUNOLOGY | CHILDREN | IMPAIRMENT | HEARING-LOSS | INCLUSION DISEASE | VIRUS INFECTION | INFANTS | PEDIATRICS | BIRTH | Strabismus - etiology | Eye Infections, Viral - congenital | Eye Infections, Viral - complications | Cytomegalovirus Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Cytomegalovirus Infections - complications | Gestational Age | Strabismus - epidemiology | Young Adult | Birth Weight | Adolescent | Adult | Female | Cytomegalovirus Infections - congenital | Vision Disorders - epidemiology | Child | Chronic Disease | Longitudinal Studies | Eye Infections, Viral - epidemiology | Infant, Newborn | Vision Disorders - etiology | Long-term | Sequelae | CMV | Congenital Cytomegalovirus | Visual
sequelae | visual | cytomegalovirus | congenital cytomegalovirus | long-term | MORTALITY | INFECTIOUS DISEASES | IMMUNOLOGY | CHILDREN | IMPAIRMENT | HEARING-LOSS | INCLUSION DISEASE | VIRUS INFECTION | INFANTS | PEDIATRICS | BIRTH | Strabismus - etiology | Eye Infections, Viral - congenital | Eye Infections, Viral - complications | Cytomegalovirus Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Cytomegalovirus Infections - complications | Gestational Age | Strabismus - epidemiology | Young Adult | Birth Weight | Adolescent | Adult | Female | Cytomegalovirus Infections - congenital | Vision Disorders - epidemiology | Child | Chronic Disease | Longitudinal Studies | Eye Infections, Viral - epidemiology | Infant, Newborn | Vision Disorders - etiology | Long-term | Sequelae | CMV | Congenital Cytomegalovirus | Visual
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 13, pp. 2695 - 2703
Viral infections and leukemic relapse account for the majority of treatment failures in patients with B-cell acute lymphoblastic leukemia (B-ALL) receiving...
ALLOGENEIC TRANSPLANTATION | ADOPTIVE TRANSFER | IMMUNOTHERAPY | BONE-MARROW-TRANSPLANTATION | ACUTE LYMPHOBLASTIC-LEUKEMIA | RISK | ADENOVIRUS INFECTION | CYTOMEGALOVIRUS | HEMATOLOGY | 1ST COMPLETE REMISSION | CHEMOTHERAPY | Recombinant Fusion Proteins - immunology | T-Lymphocyte Subsets - immunology | Recurrence | T-Lymphocyte Subsets - cytology | Humans | Postoperative Complications - prevention & control | Cells, Cultured - transplantation | Neoplastic Stem Cells - immunology | Receptors, Antigen, T-Cell, alpha-beta - immunology | Adoptive Transfer | Coxsackie and Adenovirus Receptor-Like Membrane Protein | Receptors, Virus - genetics | Blood Cells - immunology | Feasibility Studies | Receptors, Virus - physiology | Postoperative Complications - virology | Single-Chain Antibodies - genetics | T-Lymphocytes, Cytotoxic - transplantation | Adult | Adenoviridae - immunology | Cells, Cultured - immunology | Antigens, CD19 - immunology | Recombinant Fusion Proteins - biosynthesis | T-Lymphocytes, Cytotoxic - immunology | Virus Diseases - immunology | Leukemia, B-Cell - pathology | Fetal Blood - cytology | T-Lymphocyte Subsets - transplantation | Antigens, Viral - immunology | Cytomegalovirus - immunology | Cell Line, Tumor - immunology | In Vitro Techniques | Leukemia, B-Cell - immunology | T-Lymphocytes, Cytotoxic - cytology | Cell Line, Transformed | Interferon-gamma - biosynthesis | Single-Chain Antibodies - immunology | Virus Diseases - prevention & control | Transplantation
ALLOGENEIC TRANSPLANTATION | ADOPTIVE TRANSFER | IMMUNOTHERAPY | BONE-MARROW-TRANSPLANTATION | ACUTE LYMPHOBLASTIC-LEUKEMIA | RISK | ADENOVIRUS INFECTION | CYTOMEGALOVIRUS | HEMATOLOGY | 1ST COMPLETE REMISSION | CHEMOTHERAPY | Recombinant Fusion Proteins - immunology | T-Lymphocyte Subsets - immunology | Recurrence | T-Lymphocyte Subsets - cytology | Humans | Postoperative Complications - prevention & control | Cells, Cultured - transplantation | Neoplastic Stem Cells - immunology | Receptors, Antigen, T-Cell, alpha-beta - immunology | Adoptive Transfer | Coxsackie and Adenovirus Receptor-Like Membrane Protein | Receptors, Virus - genetics | Blood Cells - immunology | Feasibility Studies | Receptors, Virus - physiology | Postoperative Complications - virology | Single-Chain Antibodies - genetics | T-Lymphocytes, Cytotoxic - transplantation | Adult | Adenoviridae - immunology | Cells, Cultured - immunology | Antigens, CD19 - immunology | Recombinant Fusion Proteins - biosynthesis | T-Lymphocytes, Cytotoxic - immunology | Virus Diseases - immunology | Leukemia, B-Cell - pathology | Fetal Blood - cytology | T-Lymphocyte Subsets - transplantation | Antigens, Viral - immunology | Cytomegalovirus - immunology | Cell Line, Tumor - immunology | In Vitro Techniques | Leukemia, B-Cell - immunology | T-Lymphocytes, Cytotoxic - cytology | Cell Line, Transformed | Interferon-gamma - biosynthesis | Single-Chain Antibodies - immunology | Virus Diseases - prevention & control | Transplantation
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2007, Volume 45, Issue 9, pp. 1120 - 1131
Background. Recently, epidemiological and clinical data have revealed important changes with regard to clinical adenovirus infection, including alterations in...
Adenoviruses | Vaccination | Articles and Commentaries | Adenoviridae infections | Specimens | Chronic diseases | Bone marrow | Infections | Children | Epidemiology | Genotypes | VIRAL INFECTIONS | INFECTIOUS DISEASES | ACUTE RESPIRATORY ILLNESS | CONTINUING SURVEILLANCE | MICROBIOLOGY | ENTERIC IMMUNIZATION | IMMUNOLOGY | TYPE-21 VACCINE | POLYMERASE-CHAIN-REACTION | MILITARY RECRUITS | MOLECULAR EPIDEMIOLOGY | GENOME TYPE | VIRUS WATCH PROGRAM | United States - epidemiology | Prevalence | Humans | Middle Aged | Risk Factors | Child, Preschool | Genotype | Infant | Male | Adenovirus Infections, Human - epidemiology | Adenoviridae - isolation & purification | Adenovirus Infections, Human - classification | Adolescent | Adenoviridae - genetics | Adult | Female | Adenoviridae - classification | Microbiological Techniques | Child | Adenovirus Infections, Human - virology | Nucleotide sequence | Demographic aspects | Adenovirus diseases | Genetic aspects | Forecasts and trends | Virulence (Microbiology) | Research | Methods | Risk factors
Adenoviruses | Vaccination | Articles and Commentaries | Adenoviridae infections | Specimens | Chronic diseases | Bone marrow | Infections | Children | Epidemiology | Genotypes | VIRAL INFECTIONS | INFECTIOUS DISEASES | ACUTE RESPIRATORY ILLNESS | CONTINUING SURVEILLANCE | MICROBIOLOGY | ENTERIC IMMUNIZATION | IMMUNOLOGY | TYPE-21 VACCINE | POLYMERASE-CHAIN-REACTION | MILITARY RECRUITS | MOLECULAR EPIDEMIOLOGY | GENOME TYPE | VIRUS WATCH PROGRAM | United States - epidemiology | Prevalence | Humans | Middle Aged | Risk Factors | Child, Preschool | Genotype | Infant | Male | Adenovirus Infections, Human - epidemiology | Adenoviridae - isolation & purification | Adenovirus Infections, Human - classification | Adolescent | Adenoviridae - genetics | Adult | Female | Adenoviridae - classification | Microbiological Techniques | Child | Adenovirus Infections, Human - virology | Nucleotide sequence | Demographic aspects | Adenovirus diseases | Genetic aspects | Forecasts and trends | Virulence (Microbiology) | Research | Methods | Risk factors
Journal Article